Imaging and pathology analysis to predict prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study uses advanced imaging scans (MRI and ultrasound) and lab analysis of tissue samples to better predict prostate cancer. If you've had or are planning a prostate biopsy or surgery, your imaging and tissue results could help doctors develop better tools to diagnose prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had or are scheduled to have a prostate biopsy (needle sample) or prostate removal surgery
- You completed MRI and ultrasound imaging scans of your prostate before or after the procedure
- You have a final pathology report (tissue diagnosis) from your biopsy or surgery
- You are between 40 and 90 years old
- You can provide written consent to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new computer program that reads prostate MRI images to help doctors diagnose prostate cancer more accurately. It may help you by providing a clearer picture of your condition without extra tests.
This study tests whether new MRI imaging methods can better identify and grade prostate cancer in men with elevated PSA levels. You would get an MRI scan to help doctors see if cancer is present and how aggressive it might be.
This study looks at using advanced MRI techniques to better spot prostate cancer, aiming to reduce unnecessary biopsies. It has two parts: one calibrates MRI scanners across hospitals, the other tests the new method in patients with suspicious MRI findings.
This trial uses repeated MRI scans to monitor prostate lesions that have a low chance of being aggressive cancer. It is for people who have suspicious spots but whose initial biopsies did not find high-grade cancer.
This study tests a new biopsy system that uses MRI images and metabolic information to guide doctors to the most suspicious areas of the prostate during the biopsy. This could make the biopsy more accurate and help diagnose prostate cancer better.
This study is testing whether artificial intelligence can better predict prostate cancer by combining two types of scans (MRI and PSMA PET) along with your medical history, PSA, and biopsy results. If you have already had these scans and a biopsy, your information may help researchers develop a more accurate, non-invasive diagnostic tool.
Hear when a new Prostate Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.